Bayer AG
XBSE:BAYN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bayer AG
XBSE:BAYN
|
DE |
|
C.Uyemura & Co Ltd
OTC:CUYRF
|
JP |
|
F
|
Frey SA
PAR:FREY
|
FR |
|
F
|
Fortuna Metals Ltd
XMUN:TG5
|
AU |
Intrinsic Value
Is BAYN undervalued or overvalued?
See the intrinsic value estimate for 
Bayer AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Bayer Does
Bayer AG is a life sciences company that makes medicines and crop protection products. In human health, it sells prescription drugs and consumer health products used for areas like heart disease, women’s health, eye care, and pain relief. In agriculture, it sells seeds, traits, herbicides, fungicides, and digital farming tools that help farmers protect crops and improve yields.
- Headquarters
- Germany DE
- Employees
- 88 078
- IPO date
- Nov 28, 1997
Bayer has no economic moat
Patent protection gives Bayer an advantage in some medicines, but it does not prevent cheaper copies from taking business once that protection ends. Competition from generic medicines and crop chemicals limits Bayer’s ability to keep charging higher prices across its businesses.
Read the full moat analysis
Revenue & Expenses Breakdown
Bayer AG
Earnings Waterfall
Bayer AG
The intrinsic value for Bayer AG (BAYN) under the Base Case is hidden RON.
Compared with the current market price of 141.5 RON, the stock appears hidden.
